Please provide your email address to receive an email when new articles are posted on . The FDA granted breakthrough device designation and permitted marketing for the first in vitro diagnostic test ...

The FDA cleared its first in vitro test to help determine whether people showing signs of cognitive decline also carry one of the hidden hallmarks of Alzheimer’s disease. The diagnostic detects ...

Credit: Getty Images. The Lumipulse G β-Amyloid Ratio (1-42/1-40) test is intended to be used as an aid in adults 55 years of age and older presenting with cognitive impairment who are being evaluated ...

Common Mistakes to Avoid in Order to Improve Translation of Interaction Data to the Clinic Since 2006, when the U.S. FDA published a draft guidance on drug interaction studies, it has expected new ...

SAN DIEGO--(BUSINESS WIRE)--ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced that it has received UK Conformity Assessed (UKCA) ...

In the wake of the FDA handing down its first clearance for an in vitro test for early-stage Alzheimer’s disease in May, the floodgates have been opened. Among the next diagnostics on the agency’s ...

For example, the hemoglobin denaturation (HD) test and the Ocular Irritection test are in chemico alternatives to the Draize rabbit test. The Draize rabbit test was developed in 1944 to test cosmetic ...

Please provide your email address to receive an email when new articles are posted on . One of the major challenges in the field of nanomedicine is translating in vitro performance of nanoparticles to ...

The Saudi Arabia in vitro diagnostics (IVD) market is set for steady growth, driven by the increasing prevalence of chronic ...